Therapeutic Asset Ratings

247 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Gumarontinib Non-Small Cell Lung Carcinoma	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P2	CC (46)
ltc004 Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P2	CC (46)
URSODEOXYCHOLIC ACID Breast Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P2	CC (46)
bmd006 Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
ce120 Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
Crept-618 Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
Glecirasib KRAS G12C	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
Idov-Safetm Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
Immunoglobulin G1 [de-448-lysine], anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 ?1-chain) fusion protein with peptide linker (GGGGS)2 fusion protein with immunoglobulin anti-(human epidermal growth factor receptor HER3) (human clone HER3.H3 single-chain variable fragment VH-(GGGGS)3-VL), complex with human-mouse monoclonal C225 ?-chain, dimer, 214??,214???,222,222?,228,228?,231,231?-octakis(thioether) with (2S)-N-(carboxymethyl)-2-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-?-alanylglycylglycyl-L-phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3?,4?:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-1-methyl-2-oxoethoxy]methyl]glycinamide Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
Ivonescimab KRAS G12C	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
kxv01 tcr lentinvivo Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
lyc001 Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
Meta10-Til Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
mt027 Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
nk510 Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
prg2505 Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
qh101 Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
Taest1901 Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
Tc-N201 Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
Vsv Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
yl-201 Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
Ysch-01 Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
gc511b car-t cell Small Cell Lung Carcinoma	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1	CC (43)
Human Single Chain Il-12 Mrna-Multiple Dose Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1	CC (43)
bmd006 Metastatic Malignant Neoplasm	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (43)

Showing 151 to 175 of 247 assets

PreviousPage 7 of 10Next